Document is current
Any future updates will be listed below
-
Authors
Bögli, Stefan Yu
Olakorede, Ihsane
Smith, Claudia Ann
Czosnyka, Marek
Hutchinson, Peter
Agrawal, Shruti
Smielewski, Peter
,
Agrawal, Shruti
Smielewski, Peter
Hutchinson, Peter J.
Bögli, Stefan Yu
Smith, Claudia A.
Tooke, Carly
Payne, Caroline
Belfield, Holly
Mistry, Amisha
Spencer, Collette
Jennings, Claire
Bunni, Lara
Anderson, Laura
Morgan, Emily
James, Melanie
Beckley, Rebecca
Khatun, Tahnima
Khatun, Hafiza
Nugent, Olivia
Aldridge, Richard
Morgan, Ruth
Morcombe, Julie
Quinton, Martin
Postlethwaite, Catherine
Pond, Jenny
Cutler, Jessica
Oxford, Caitlin
Czosnyka, Marek
Placek, Michal
Cabaleira, Manuel
White, Deborah
Daubney, Esther
Young, Adam
Beqiri, Erta
Kayani, Riaz
O’DonneII, Roddy
Pathan, Nazima
Watson, Suzanna
Maw, Anna
Garnett, Matthew
Kanthimathinathan, Hari Krishnan
Bangalore, Harish
Sundararajan, Santosh
Subramanian, Gayathri
Raffaj, Dusan
Lampariello, Simona
Sarfatti, Avishay
Mayer, Anton
Ross, Oliver
-
Funding
Funding for this research was provided by:
Swiss National Science Foundation (210839/225270)
Patrick & Margaret Flanagan Skye Cambridge Trust Scholarship
Action Medical Research for Children’s Charity (GN2609, GN2609, GN2609)
NIHR
- License Information
-
More Information
Article History
Received: 14 February 2025
Accepted: 4 April 2025
First Online: 2 June 2025
Declarations
:
: The STARSHIP trial was approved by the Health Research Authority, Southwest-Central Bristol Research Ethics Committee (Ref: 18/SW/0053).
: Due to the observational nature of the acute phase of the project, a deferred consent for acute data collection and sharing was taken to allow for the acquisition of a bias-free sample. Informed consent was received by the patients’ legal guardian for data sharing and follow-up before discharge.
: Not applicable.
: Peter Smielewski and Marek Czosnyka receive part of the licensing fees for ICM + software, licensed by Cambridge Enterprise Ltd, University of Cambridge, Cambridge. The other authors declare no financial or non-financial conflicts of interest.
